| Sep 26 |
enVVeno Medical offers to sell common stock
|
| Sep 26 |
enVVeno Medical Corporation Announces Proposed Public Offering
|
| Aug 14 |
enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
|
| Aug 10 |
Here's Why We're Not Too Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Situation
|
| Jun 25 |
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
|
| Jun 17 |
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
|
